Clinical Trials Logo

Lung Cancer Stage 1 clinical trials

View clinical trials related to Lung Cancer Stage 1.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03682224 Completed - Clinical trials for Non Small Cell Lung Cancer

Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients

BEMP
Start date: July 5, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess pain management after elective thoracoscopic lobectomy. The study will compare two local anesthetics that are given intra-operatively during lobectomy to see which one helps in better pain control and to see which one helps decrease the need for opioid medications. Participants will receive either Marcaine (Bupivacaine-epinephrine 0.25%, 1:200,000) or Exparel (Bupivacaine liposomal (1.3%)) and the drug will be chosen in a random fashion. Participants will be followed during the hospital stay and for one year thereafter. An visual Scale will be administered to measure pain, and opioid drug use will be measured by calculating morphine equivalent dose on each day post surgery until discharge and thereafter on 30 day, 6 month and 12 month follow-up visits. Participants will be monitored for any drug related toxicity and other co-morbid conditions for a period on one year post surgery. Overall cost for the surgery and during in hospital stay post surgery will be collected and compared between the two treatment arms.